लोड हो रहा है...
Erenumab: A novel calcitonin gene-related peptide receptor antagonist developed specifically for migraine prevention
Headaches and migraines continue to be a leading cause of suffering and disability. As per the Global Burden of Disease Survey conducted in 2010, the exact magnitude of the disease still is underestimated. Migraine alone continues to rank seventh as a cause of disability. Various therapeutic modalit...
में बचाया:
| में प्रकाशित: | J Anaesthesiol Clin Pharmacol |
|---|---|
| मुख्य लेखकों: | , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Wolters Kluwer - Medknow
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7047699/ https://ncbi.nlm.nih.gov/pubmed/32174669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/joacp.JOACP_3_19 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|